ofranergene,vb-111
nanocarrier,vbl therapeutics
['oval,(-approval)', 'vb-111', 'pivotal', 'ovarian']
#asco22 | poster 479b | sat 1:15pm cdt
pivotal study of ofra-vec (vb-111) combined with paclitaxel versus paclitaxel for treatment of platinum-resistant ovarian cancer (oval, vb-111-701/gog-3018).
presenter: richard t. penson, md, mrcp 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.